XML 45 R31.htm IDEA: XBRL DOCUMENT v3.24.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2023
Income Taxes  
Schedule of components of provision for income taxes

The significant components of the provision for income taxes for the years ended December 31, 2023 and 2022 were as follows (in thousands):

    

2023

    

2022

Current income tax expense (benefit):

 

  

 

  

Foreign

$

1,181

$

1,131

Federal

 

120

 

144

State and local

 

3

 

30

 

1,304

 

1,305

Deferred income tax expense (benefit):

 

  

 

  

Foreign

 

(286)

 

207

Federal

 

10

 

10

State and local

 

-

 

-

 

(276)

 

217

Provision for income taxes

$

1,028

$

1,522

Schedule of reconciliation of U.S. statutory rate with Company's effective tax rate

The reconciliation of the U.S. statutory rate with the Company’s effective tax rate for the years ended December 31, 2023 and 2022 is summarized as follows:

    

2023

    

2022

 

Federal income tax expense (benefit) at statutory rate

 

21.0

%  

(21.0)

%

Effect of:

 

 

Change in valuation allowance

 

578.6

 

36.9

Tax effects of foreign operations

 

562.6

 

2.5

Section 162 (m)

452.0

-

Return to provision true up

 

264.4

 

0.3

Increase in unrecognized tax benefits (ASC 740)

 

199.6

 

0.7

Withholding tax

106.6

-

Foreign operations permanent differences - foreign exchange gains and losses

76.9

1.1

State income tax net of federal benefit

 

0.1

 

0.2

Research and development credit

(67.3)

-

Foreign rate differential

 

(102.5)

 

(4.7)

Deemed interest

(149.2)

(1.9)

Tax effect of intercompany settlement

(234.0)

-

Effect of stock-based compensation

 

(961.6)

 

(0.3)

Other

(7.6)

0.7

Effective tax rate

 

739.6

%  

14.5

%

Schedule of deferred tax assets and liabilities

Deferred tax assets and liabilities are classified as non-current. Significant components of the Company’s deferred tax assets and liabilities as of December 31, 2023 and 2022 were as follows (in thousands):

December 31, 

    

2023

    

2022

Deferred income tax assets:

 

  

 

  

Allowances not currently deductible

$

283

$

301

Depreciation and amortization

 

58

 

9

Equity compensation not currently deductible

 

2,098

 

1,579

Net operating loss carryforwards

 

10,514

 

10,758

Research and development credits

452

362

Expenses not deductible until paid

 

1,972

 

1,694

Other

 

133

 

(220)

Total gross deferred income tax assets before valuation allowance

 

15,510

 

14,483

Valuation allowance

 

(13,769)

 

(13,008)

Deferred income tax assets, net

1,741

1,475

Deferred income tax liabilities:

 

  

 

  

Other

 

(22)

 

(65)

Total deferred income tax liabilities

 

(22)

 

(65)

Net deferred income tax assets

$

1,719

$

1,410

Net deferred income tax assets

$

1,741

$

1,475

Net deferred income tax liability

(22)

(65)

Net deferred income tax assets

$

1,719

$

1,410

Schedule of United States and foreign components of loss before provision for income taxes

United States and foreign components of loss before provision for income taxes for each of the years ended December 31, were as follows (in thousands):

2023

2022

United States

$

2,025

$

(4,023)

Foreign

 

(1,886)

 

(6,460)

Totals

$

139

$

(10,483)

Schedule of roll forward of the Company's unrecognized tax benefits and associated interest

The following table represents a roll forward of the Company’s unrecognized tax benefits and associated interest for the years ended (in thousands):

Unrecognized Tax

Benefits

December 31, 

    

2023

    

2022

Balance at January 1

$

1,680

$

1,753

Decrease for prior year tax positions

 

(68)

 

(290)

Increase for current year tax positions

 

247

 

311

Interest accrual

 

97

 

67

Foreign currency remeasurement

 

(14)

 

(161)

Balance at December 31

$

1,942

$

1,680